HIND: Rega marang dodolan Vyome Therapeutics

Logo korporat perusahaan ReShape Lifesciences (HIND)

Vyome Holdings Inc delegates clinical testing and product manufacturing to external contractors, creating a heavy reliance on vendors. The P/S multiple trend on GURU.Markets visualizes this process, with the current metric standing at 71.50. The company is also implementing minimally invasive obesity treatments in collaboration with clinics, while simultaneously modernizing its facilities to scale immunotherapy production in the future.

ReShape Lifesciences - Kapitalisasi marang pendapatan HIND (periode 16.08.2025 - 17.11.2026)

Rincian metrik lan analitis perusahaan reshapelifesciences.com (HIND)

- rega saham lan target rega konsensus:
Analisis umum perusahaan:HIND - ReShape Lifesciences
Produk seri Vyome Holdings Inc

The P/S ratio determines the market value of a unit of revenue, allowing for the identification of fair business valuation boundaries through the analysis of price corridors and export potential. By analyzing the divergence of the P/S from its historical average, an investor assesses whether the asset is overbought, taking into account the impact of Vyome Holdings Inc. (HIND) strict ESG standards regarding chemical waste disposal on the company's long-term capitalization.

Karo sapa Vyome Holdings Inc saingan

argenx - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (biontech.de)|Abivax Corp (ABVX) - Rega marang dodolan|ADMA Corp - Multiplikator P/S|Rasio rega marang dodolan PTGX|Immunovant Inc (IMVT) - Rasio rega marang pendapatan|KNSA - Koefisien rega marang pendapatan|GRFS (Grifols Biemat) - Multiplikator P/S|Multiplikator P/S Adaptive Biotechnologies Inc.|Rasio rega marang pendapatan Celldex Therapeutics (CLDX)|Koefisien rega marang pendapatan auriniapharma.com|Rasio rega marang pendapatan BioCryst Pharmaceuticals BCRX|Rasio kapitalisasi pasar marang pendapatan VERA|Dianthus Pharma - Multiplikator P/S|PHVS - Multiplikator P/S|ABCL: Multiplikator P/S|TRML (Tourmaline Bio, Inc.) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Intrexon|PHAR - Multiplikator rega marang pendapatan|Multiplikator P/S NKTR|Rasio rega marang pendapatan UPB (Upstream Bio Corp)|Rasio rega marang pendapatan Zenas Biopharma, Inc. ZBIO|Koefisien rega marang pendapatan immunome.com (IMNM)|Gossamer Bio Inc - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Multiplikator P/S|Kapitalisasi marang pendapatan Pieris Pharmaceuticals Inc|Kapitalisasi marang pendapatan SVRA|Kapitalisasi marang pendapatan Rigel Pharmaceuticals (RIGL)|Multiplikator P/S ANAB|ATXS - Rega marang dodolan|Rasio rega marang pendapatan enGene Corp ENGN|Koefisien rega marang pendapatan RAPT Therapeutics, Inc. (RAPT)|Aerovate - Multiplikator P/S|ACRS - Multiplikator P/S|KYTX (Kyverna Therapeutics) - Kapitalisasi marang pendapatan|Rega marang dodolan Tiziana Life Sciences Ltd. (TLSA)|Kapitalisasi marang pendapatan CABA|Ventyx Biosciences (VTYX) - Koefisien rega marang pendapatan|Multiplikator P/S THTX|AVTX (Avalo Therapeutics, Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ELDN (eledon.com)|AGEN - Kapitalisasi marang pendapatan|CLYM - Rasio rega marang pendapatan|Rasio rega marang dodolan ZURA|ATYR: Multiplikator P/S|Adagene Corp (ADAG) - Multiplikator P/S|Kapitalisasi marang pendapatan IMA|Shattuck Labs, Inc. - Rasio rega marang dodolan|Rasio rega marang pendapatan Equillium Inc (EQ)|Multiplikator P/S Connect Biopharma Holdings (CNTB)|Rasio rega marang pendapatan Immunic, Inc. IMUX|Multiplikator P/S Atara Biotherapeutics ATRA|IFRX - Rasio rega marang pendapatan|XFOR: Rasio rega marang pendapatan|ACET: Multiplikator P/S|CELU - Koefisien rega marang pendapatan|Rasio rega marang pendapatan inmunebio.com|Rasio kapitalisasi marang pendapatan BRNS (barinthusbio.com)|Multiplikator P/S KZR|Multiplikator P/S SAB Biotherapeutics, Inc (SABS)|Multiplikator P/S AKTX (Akari Therapeutics, Plc)|Multiplikator P/S enlivex.com ENLV|QTTB: Kapitalisasi marang pendapatan|GOVX - Multiplikator P/S|Edesa Biotech Inc (EDSA) - Rasio rega marang pendapatan|IBIO - Koefisien rega marang pendapatan|Rasio rega marang pendapatan carismatx.com|XTLB: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan aptevotherapeutics.com APVO|AIM - Kapitalisasi marang pendapatan|Aditxt - Multiplikator P/S|Koefisien rega marang pendapatan GRI Bio Corporation GRI|xortx.com (XRTX) - Rasio rega marang pendapatan|revbiosciences.com (REVB) - Multiplikator P/S|INDP (Indaptus Corp) - Multiplikator P/S|Kapitalisasi marang pendapatan Scinai Immunotherapeutics Ltd (SCNI)|Rasio rega marang pendapatan CalciMedica Inc (CALI)|AFMD (Affimed NV) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ALLK (Allakos Inc.)|Multiplikator P/S HOOKIPA HOOK|IGMS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ITOS (iTeos)|OCEA: Multiplikator P/S|TCBP (TC BioPharm Ltd) - Rasio rega marang pendapatan|THRD (Third Harmonic Bio Inc) - Multiplikator P/S